Jeevadravya Bio-Pharma Profile
Key Indicators
- Authorised Capital ₹ 324.05 Cr
as on 25-06-2024
- Paid Up Capital ₹ 242.01 Cr
as on 25-06-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit 88.19%
(FY 2021)
- Ebitda 88.19%
(FY 2021)
- Net Worth -0.12%
(FY 2021)
- Total Assets -0.11%
(FY 2021)
About Jeevadravya Bio-Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 324.05 Cr and a paid-up capital of Rs 242.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tushar Modak and Dattatraya Dhavalikar serve as directors at the Company.
- CIN/LLPIN
U24304PN2018PTC178826
- Company No.
178826
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jeevadravya Bio-Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Modak  | Director | 15-Feb-2020 | Current |
| Dattatraya Dhavalikar | Director | 19-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Jeevadravya Bio-Pharma.
Jeevadravya Bio-Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 88.19% increase in profit. The company's net worth dipped by a decrease of 0.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeevadravya Bio-Pharma?
In 2020, Jeevadravya Bio-Pharma had a promoter holding of 99.90% and a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jeevadravya Bio-Pharma?
Unlock and access historical data on people associated with Jeevadravya Bio-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeevadravya Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeevadravya Bio-Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
